tiprankstipranks
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF

Chugai Pharmaceutical Co (CHGCF) Financial Statements

13 Followers

Chugai Pharmaceutical Co Financial Overview

Chugai Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $1.373; its P/E ratio is 27.12; and it has a dividend yield of 1.45%. Chugai Pharmaceutical Co is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $0.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue¥ 225.28B¥ 235.61B¥ 360.56B¥ 322.27B¥ 287.26B
Gross Profit¥ 156.19B¥ 155.79B¥ 246.13B¥ 211.71B¥ 183.07B
EBIT¥ 95.05B¥ 100.73B¥ 186.22B¥ 138.45B¥ 119.70B
EBITDA¥ 95.05B¥ 100.73B¥ 186.22B¥ 138.45B¥ 119.70B
Net Income Common Stockholders¥ 67.80B¥ 72.38B¥ 131.78B¥ 98.84B¥ 86.02B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 545.29B¥ 592.24B¥ 431.82B¥ 471.97B¥ 396.65B
Total Assets¥ 1.70T¥ 1.63T¥ 1.58T¥ 1.54T¥ 1.35T
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -545.29B¥ -592.24B¥ -431.82B¥ -471.97B¥ -396.65B
Total Liabilities-¥ 318.26B¥ 344.44B¥ 350.68B¥ 262.71B
Stockholders Equity¥ 1.31T¥ 1.31T¥ 1.24T¥ 1.19T¥ 1.09T
Cash Flow-
Free Cash Flow¥ 16.27B¥ 159.86B¥ 35.75B¥ 87.11B¥ 56.52B
Operating Cash Flow¥ 25.19B¥ 173.39B¥ 72.54B¥ 94.96B¥ 81.67B
Investing Cash Flow¥ -47.45B¥ -42.55B¥ -33.98B¥ -17.17B¥ -25.16B
Financing Cash Flow¥ -63.98B¥ -2.44B¥ -76.87B¥ -2.98B¥ -51.04B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History

Chugai Pharmaceutical Co Debt to Assets

Chugai Pharmaceutical Co Cash Flow

Chugai Pharmaceutical Co Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis